Introduction
Pandemic influenza A (H1N1) 2009 virus was documented for the first time in humans in North America in April 2009. Subsequently, it spread rapidly to the rest of the world and was declared to be a pandemic infection [1] .
192 verbal: incoherent words -3). Her temperature was 38 ° C, heart rate was 116 beats/min; the O 2 saturation was 98% in room air and blood pressure was 100/70 mm Hg. There was no skin rash. Central nervous system examination showed normal tone, power of 5/5 in 4 limbs, normal reflexes, and intact cranial nerves. There were no signs of meningeal irritation, pupils were equal and reactive, and there was no papiloedema. Examination of other organs was unremarkable. Soon after admission she was transferred to the pediatric ICU. Meningoencephalitis was suspected and full septic workup was performed, including complete blood count, C-reactive protein, blood and urine cultures, CSF for biochemistry and culture, virology tests by PCR on blood, nasal swab, and CSF. She was started empirically on i.v. acyclovir (60 mg/kg/day), i.v. cefotaxime (200 mg/kg/day), and oral oseltamivir (90 mg/day) was continued. Laboratory investigations were as follows. Complete blood count: WBC 4.2 ! 10 9 /l (23% neutrophils, 70% lymphocytes) with an absolute neutrophil count of 1.0 ! 10 9 /l, hemoglobin 139 g/l, platelets 162 ! 10 9 /l. Renal and liver function tests were normal. C-reactive protein: negative. Coagulation profile: normal. Nasal swab specimen for pandemic influenza A (H1N1) test (by reverse-transcription PCR) was repeated and it was positive. Nasal swab was tested for other viruses (adenovirus, influenza b virus, para-influenza virus, rhinovirus, corona, and RSV virus) and was negative. A CSF analysis was taken on the seventh day of the illness: WBC ! 4 mm 3 , RBC ! 4 mm 3 , protein 549 mg/l, glucose 2.8 mmol/l, lactate dehydrogenase 18 U/l, lactate 1.35 mmol/l. Direct smear revealed no micro-organisms. Tests for bacterial antigens were negative. Culture was negative after 48 h. CSF was negative for pandemic influenza A (H1N1) virus, herpes simplex virus, human herpes virus 6, and enterovirus by PCR; Varicella-Zoster was not tested.
MRI of her head with contrast showed a focal area of bright signal intensity with blurring of cortical ribbon seen on T2W1 and FLAIR sequence. This is seen as low signal intensity on T1W1 ( fig. 1 ). Post-contrast study revealed only focal linear meningeal enhancement in the right frontal region. There was no evidence of parenchymal enhancement ( fig. 2 ). These features were consistent with the diagnosis of meningoencephalitis. EEG showed a generalized slowing suggestive of an encephalopathic process. With this clinical picture, results of nasal swab and MRI finding, encephalitis was suspected, most likely due to pandemic influenza A (H1N1) 2009 influenza infection. The patient received oral oseltamivir for 5 days, i.v. cefotaxime, and i.v. acyclovir were discontinued once the cultures and virology test became negative. While in the pediatric ICU, she had acutely raised creatinine levels (122 umol/l). This was thought to be secondary to i.v. medication (acyclovir) or i.v. contrast. It was managed by i.v. fluid, and the dose of acyclovir was reduced. The rest of her renal function tests were normal.
She stayed in the pediatric ICU for 4 days and was then transferred to the ward. In the ward, she was conscious with a Glasgow Coma Scale score of 15/15. She looked generally weak, not interested in talking and avoiding eye contact. Her speech was monotonic. She had a mild tremor and incoordination of her limbs. She gradually improved and on discharge returned to her normal behavior and activity. Her central nervous system examination was normal.
Discussion
Neurological complications associated with seasonal influenza virus have been reported for more than 100 years. Historical records reveal that in 1918, more than 40 million people died due to an influenza pandemic, which was rapidly followed by an epidemic of encephalitis lethargica in 1919 [3] . The capability of seasonal influenza virus to cause neurological complications is well documented in the literature. These complications include influenza-associated encephalitis/encephalopathy, myelitis, seizures, Reye syndrome and acute necrotizing encephalitis [4] .
Influenza virus infection was associated with 5% of cases of acute childhood encephalitis/encephalopathy [5] . The majority of these children were ! 5 years of age. The prevalence of neuroimaging abnormalities was higher in children ! 2 years of age, suggesting that younger children are more predisposed to the neurologic complications of influenza. In addition, acute rather than a postinfectious process was suggested by the briefness of the respiratory prodrome in most cases [5] . The epidemiology of influenza-associated encephalopathy has been described extensively in Japan where the incidence has appeared to be higher than in other countries [4] . A national survey of influenza-associated encephalopathy was carried out in Japan between 1998 and 2002. This survey found that the majority of patients had relatively minor neurological symptoms. However, a small but significant number experienced serious complications, resulting in neurologic sequelae or even death [6] . This highlights the seriousness of neurologic complications of the influenza virus. The pathogenesis of influenza-associated encephalitis/encephalopathy is unclear, and whether the influenza virus invades the brain parenchyma is still a controversial issue. Viral RNA was frequently detected in the CSF by reverse-transcription PCR [4] . However, recent reports have indicated that viral RNA is not detected in the CSF of most patients with influenza-associated encephalitis/encephalopathy [4] . Influenza A virus strains with certain hemagglutinin (H) and neuraminidase (N) profiles are more often associated with CNS complications; in particular, influenza A (H3N2) virus infections have been found in the majority of encephalopathy cases reported in Japan and Europe [6] . Avian influenza A H5N1 virus has been shown to target the nervous system in post-mortem studies. Its viral genomic sequences and antigens were detected in neurons of the brain as well as other organs in fatal cases of avian A H5N1 [7] . was defined as having laboratory-confirmed pandemic influenza A (H1N1) 2009 virus infection of the respiratory tract associated with seizures, encephalopathy, or encephalitis within 5 days of influenza-like illness symptoms, without evidence of an alternative etiology. Encephalopathy was defined as altered mental status lasting for 24 h and encephalitis was defined as encephalopathy plus 2 or more of the following: fever of 6 38.0 ° C, focal neurologic signs, CSF pleocytosis, EEG indicative of encephalitis or abnormal neuroimaging indicative of infection or inflammation. In this report, 4 patients had acute neurologic complications associated with pandemic influenza A (H1N1) 2009 virus. The patients were between 7 and 17 years of age and all had confirmed pandemic influenza A (H1N1) 2009 in nasopharyngeal specimens but not in CSF. Three of 4 patients had abnormal EEG. All patients had normal brain imaging (CT/MRI) and all were treated with anti-influenza medications (oseltamivir 8 rimantadine) and had good recovery with no neurologic sequelae on discharge. One patient was discharged on anti-epileptic medication until follow-up [2] .
Two patients with severe neurological complications associated with pandemic influenza A (H1N1) 2009 virus infection were reported by Webster et al. [8] . Both patients were younger than 6 years old. The first had hemi-paresis and seizures and the second ascending paralysis and weakness, progressing to complete paralysis and coma within 24 h. Both required intubation and mechanical ventilation and had positive nasal swabs for pandemic influenza A (H1N1) 2009 virus, but a negative CSF PCR for H1N1 and completely normal CSF glucose, protein, and cell count. Other infectious agents were ruled out. Both cases received treatment with oral oseltamivir and systemic steroids. The second case received i.v. immunoglobulin as well. The first had a full recovery within a week, whereas the second had mild left arm weakness a month later. Sánchez-Torrent et al. [9] reported a case of a 3-month-old infant with upper respiratory tract infection followed by repeated seizures. Pandemic influenza A (H1N1) 2009 virus was isolated in both the nasopharyngeal aspirate and CSF fluid. This was the only case we found in the literature with a positive CSF for pandemic influenza A (H1N1) 2009 virus. The patient was treated with oral oseltamivir and had no neurologic sequelae. Another case of an adolescent with neuropsychiatric symptoms associated with pandemic influenza A (H1N1) 2009 virus was reported by GermanDiaz et al. [10] .
Our patient had symptoms of influenza-like illness for 5 days followed by altered mental status for 24 h. She had abnormal neuroimaging and EEG, and a completely normal CSF analysis. Pandemic influenza A (H1N1) 2009 virus was isolated in her nasal swab. She was treated with oral oseltamivir and made a full recovery. This is another case of this rare complication of the pandemic influenza A (H1N1) 2009 virus.
Neuroimaging results in influenza-associated encephalopathy might be normal, but in severe cases abnormalities can include diffuse cerebral edema and bilateral thalamic lesions. EEG might show diffuse abnormalities.
Our case, as well as previously reported cases, should alert clinicians to the potential for neurologic manifestation with the influenza virus. Therefore, clinicians should send respiratory specimens for appropriate analysis. Antiviral treatment should be initiated as soon as possible for any hospitalized patient with neurologic symptoms and suspected influenza or pandemic influenza A (H1N1) 2009 virus infection. Antiviral medications have been shown to decrease the risk of complications from influenza. However, their effectiveness in preventing influenza-associated encephalopathy sequelae is unknown.
Conclusions
For children who have influenza-like illness accompanied by unexplained seizures or mental status changes, clinicians should consider acute seasonal influenza or pandemic influenza A (H1N1) 2009 virus infection in the differential diagnosis. Respiratory specimens should be send for appropriate diagnostic tests, and empirical antiviral treatment should be initiated promptly. Febrile seizures should also be considered in the differential diagnosis of young children. Furthermore, until the diagnosis of herpes encephalitis is ruled out, i.v. acyclovir should be included in the treatment plan.
